UNC Chemistry Spinoff Wins Gates Backing

The Triangle-based UNC Chemistry spinoff company Liquidia, which is at the forefront of efforts to use nanotechnology to tackle diseases, has received a $10 million investment from the Bill & Melinda Gates Foundation. Liquidia Technologies, which was founded on the discoveries of Carolina Chemistry professor Joseph DeSimone, will use the foundation’s equity investment to support the development and commercialization of safer and more effective vaccines and therapeutics. Liquidia uses PRINT� technology, a technique invented in DeSimone’s UNC chemistry lab, to manufacture precisely engineered nano- and microparticles with control over size, shape and chemistry. It could advance the development of vaccines to prevent diseases, such as malaria, that mainly affect people in the developing world. “This technology has the potential to help countless people, maybe save millions of lives,” DeSimone said. “To have the Gates Foundation back our work is a heartening vindication of UNC’s effort to become a world leader in launching university-born ideas for the good of society.” To read more please go to the following link http://uncnews.unc.edu/content/view/4357/107/

 

 

Copyright 2014 UNC Nano · Website by AndiSites Inc.